by CANP | Oct 8, 2021 | 2021 Abstracts
Abstract 1- 0900-0915 Category: Clinical At the end of the session,participants will be able to: Identify the presence of this molecular alteration in low grade gliomas Use this important information to correlate it with clinical implications Presenter My name is...
by CANP | Oct 8, 2021 | 2021 Abstracts
Abstract 2- 0915-0930 Category: Clinical At the end of the session,participants will be able to: Understand the principal neuropathological feature that distinguishes primitive neuroblastoma from ganglioneuroblastoma Recognize the immunocytochemical neuronal markers...
by CANP | Oct 8, 2021 | 2021 Abstracts
Abstract 3- 0930-0945 Category: Clinical At the end of the session,participants will be able to: The diagnosis of malignant astrocytomas based on molecular features of IDH1 mutation may be unaccompanied by year-over-year tumor growth despite no treatment with either...
by CANP | Oct 8, 2021 | 2021 Abstracts
Abstract 4- 0945-1000 Category: Clinical At the end of the session,participants will be able to: Optimal utilization of small biopsy specimen is very important in order to facilitate complete molecular work up, from frozen section to making a diagnosis. Specific...
by CANP | Oct 8, 2021 | 2021 Abstracts
Abstract 5- 1300-1315 Category: Basic Science At the end of the session,participants will be able to: Introduce a computer-based method for the morphometric evaluation of alpha-synuclein inclusions in Multiple System Atrophy (MSA) brains. Demonstrate variability in...
by CANP | Oct 8, 2021 | 2021 Abstracts
Abstract 6- 1315-1330 Category: Clinical At the end of the session,participants will be able to: Understand the relationship between clinical manifestations and neuropathology in AD Describe the characteristics that are associated with cognitive resilience in AD...
